Two thirds of COVID-19 patients improve after Gilead drug: NEJM

  • 📰 Reuters
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc. , according to new data based on patient observation.

FILE PHOTO: A Gilead Sciences Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam/File Photo

The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included — in one case because of a dosing error. There are currently no approved treatments or preventive vaccines for COVID-19, the respiratory illness caused by the novel coronavirus that has killed more than 100,000 people worldwide.

The new analysis includes patients in the United States, Europe, Canada and Japan who received a 10-day course of intravenous remdesivir.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Is it coincidence that it’s named Gilead or is it conspiracy

This is not a scientific but commercial study! No consecutive, no randomized, even not geografical coherence... Like they have chosen some patients who had favourable outcome around the world and included in the study... No thanks!

New French study of 1000 patients claims hydroxychloroquine has a 96% effectiveness against COVID-19. WHO WSJ nytimes cnni 13NewsNow FoxNews CuomoPrimeTime TuckerCarlson dwnews NBCLatino latimes rtenews RT_com rta_dubai tulsaworld thehill QuickTake miserablelib

This is not a scientific but commercial study! No consecutive, no randomized, even not geografical coherence... Like they chose some patients who had favourable outcome around tje world and included in the study... No thanks!

JulietHuddyTV 2/3rds? Hydroxychloriquin is 100%!

Is that criminal creep Rumsfeld still on the Gilead BOD?

Reminder: no control group.

Although promising, we need meaningful, independent results.

Amazing to promote a new drug bc its from Gilead without any knowledge of side effects and basically blocking the promotion of a drug being in existence for 60+ years bc tds.. Lot of coinkidinks with Gilead.

Wonderful news now let's get back to work. moreCOVID19testlabsNOW

2/3rd improve in any case, no

No, that is not the right interpretation. NEJM this is the consequence of relaxing standards... is this a desirable outcome? COVIDー19

News like this is to just prop up the shareholders... suddenly every pharma supplier will be featured week after week to ride the hype wave I mean even tobacco corps are in for vaccines. Just waiting for oil corps to announce testing potential pills & vaccines too.

No control group? How on earth can this data be meaningful? Of course not everybody was going to die, regardless

They don't want chloroquine because it's generic. The pharmaceutical companies would rather it be something proprietary so they can make money off it.

So the 23% people will suffer deadly side effect after taking this drug?! That is too much!

No control group = no use

AlexaJetta The Handmaid’s Tale: Origins

WhatisQ

HandmaidsTaleTV

I bet you that if Trump touts it, your headline will change.

Isn't that less than those without treatment?

Great!

😡

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Misinformation, Distrust May Contribute To Black Americans' COVID-19 DeathsNPR's Noel King talks to Jahmil Lacey, a researcher on health disparities, about systemic factors that might be behind COVID-19 rates among Blacks, and why distrust in medical authorities persists.
Source: NPRHealth - 🏆 144. / 63 Read more »